Free Trial

Neurocrine Biosciences (NBIX) News Today

Neurocrine Biosciences logo
$142.74 +1.41 (+1.00%)
Closing price 04:00 PM Eastern
Extended Trading
$141.37 -1.37 (-0.96%)
As of 05:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Why Is Neurocrine Biosciences Up Today?

Neurocrine Biosciences (NASDAQ: NBIX) is trading higher after a wave of analyst activity ahead of its Q3 2025 earnings release. Investors are responding to new coverage and price-target increases that signal upside, while some previews warn the company may not have the setup for an earnings beat. Watch the Oct. 28 post-close earnings report as a potential catalyst.

Posted 58m agoAI Generated. May Contain Errors.

NBIX Latest News

Cwm LLC Raises Holdings in Neurocrine Biosciences, Inc. $NBIX
Should You be Optimistic on Neurocrine Biosciences (NBIX)?
Should You be Optimistic on Neurocrine Biosciences (NBIX)?
Where Neurocrine Biosciences Stands With Analysts
Get Neurocrine Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for NBIX and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NBIX Media Mentions By Week

NBIX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NBIX
News Sentiment

1.23

0.50

Average
Medical
News Sentiment

NBIX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NBIX Articles
This Week

24

17

NBIX Articles
Average Week

Get the Latest News and Ratings for NBIX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Neurocrine Biosciences and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:NBIX) was last updated on 10/21/2025 by MarketBeat.com Staff
From Our Partners